Create
Log in
Enquire now
Neuron23
Neuron23 is an AI-drug discovery founded in 2018 by Adam Knight.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Organization
Company
B2X
B2B
CEO
Nancy Stagliano
0
Company Operating Status
Active
Country
United States
Crunchbase URL
crunchbase.com/organiz...neuron23
Email Address
kathy@greigcommunications.com
0
info.mail@neuron23.com
0
Founded Date
2018
0
Founder
Adam Knight
0
Full Address
343 Oyster Point Blvd, Suite 120 South San Francisco, CA 94080
0
Industry
Biology
Biotechnology
Artificial Intelligence (AI)
Healthcare
Neurobiology
Medicine
Engineering
Neurological disorder
Biomedical engineering
Biopharmaceutical
•••
Investors
HBM Partners
HBM Healthcare Investments AG
Acorn Bioventures
Kleiner Perkins Caufield & Byers
SoftBank Vision Fund
Westlake Village BioPartners
Cowen Healthcare Investments
Surveyor Capital
Perceptive Advisors
Redmile Group
Latest Funding Round Date
June 24, 2025
April 1, 2022
Latest Funding Round Amount (USD)
100,000,000
96,500,000
Latest Funding Type
Series C
Series D
LinkedIn URL
@company/neuron23-inc
Location
South San Francisco, California
San Francisco
0
Number of Employees (Ranges)
51 – 200
0
Total Funding Amount (USD)
276,500,000
180,000,000
Official Website
neuron23.com
Find more companies like Neuron23
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Pricing
Enterprise
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE